1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims by Privately Insured Women

Aged 15–44 Years — United States, 2003–2015 Increased 344%

  1. Reasonable
    Study Author(s):
    Kayla N. Anderson, PhD; Elizabeth C. Ailes, PhD; Melissa Danielson, MSPH; Jennifer N. Lind, PharmD; Sherry L. Farr, PhD; Cheryl S. Broussard, PhD; Sarah C. Tinker, PhD
    Journal Name:
    Morbidity and Mortality Weekly Report, Vol 67, Issue 2: pages 66-70.
    Publication Date:
    January 19, 2018.

    What is already known about this topic?

    Attention-deficit/hyperactivity disorder (ADHD) medication use has increased among U.S. pregnant women, and consensus about its safety during pregnancy is lacking. Given that half of U.S. pregnancies are unintended, ADHD medication use among reproductive-aged women might result in early pregnancy exposure, a critical period for fetal development.

    What is added by this report?

    The percentage of privately insured reproductive-aged women who filled a prescription for an ADHD medication increased 344% from 2003 (0.9%) to 2015 (4.0%). ADHD medication prescriptions increased across all age groups and U.S. geographic regions, and the increase was confined to stimulant medications.

    What are the implications for public health practice?

    ADHD medication prescriptions are increasingly common among privately insured, reproductive-aged women. Additional research on ADHD medication safety among this population, including safety before and during pregnancy, could help women and their health care providers make evidence-based decisions concerning the risks and benefits of pharmacologic and behavioral treatment options for common conditions, including ADHD.


    1. WomenADHD.jpg
    Content to be and TheBigBadWolf like this.